Showing results (41-50 of 154) with videos related to
Sort By:
Pageof 16
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|November 7, 2022
Early or Late-Life Treatment With Acarbose or Rapamycin Improves Physical Performance and Affects Cardiac Structure in Aging MiceJonathan J Herrera, Kaitlyn Pifer, Sean Louzon, et al.Biomaterials Science|December 16, 2020
Microenvironmental determinants of organized iPSC-cardiomyocyte tissues on synthetic fibrous matricesSamuel J DePalma, Christopher D Davidson, Austin E Stis, et al.Current Protocols|April 11, 2024
In Vitro Assessment of Cardiac Fibroblast Activation at Physiologic StiffnessRobert S Goldsmith, Yao-Chang Tsan, Rachel E Scissors, et al.Circulation|October 10, 2018
Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)Carolyn Y Ho, Sharlene M Day, Euan A Ashley, et al.Cell|February 21, 2025
Advances in the study and treatment of genetic cardiomyopathiesVictoria N Parikh, Sharlene M Day, Neal K Lakdawala, et al.The American Journal of Pathology|April 3, 2012
MT1-MMP-dependent remodeling of cardiac extracellular matrix structure and function following myocardial infarctionGerald C Koenig, R Grant Rowe, Sharlene M Day, et al.Radiology. Cardiothoracic Imaging|July 16, 2026
Three-dimensional Mapping of Fibrosis Distribution in Desmoplakin Cardiomyopathy from Cardiac MRIJaviera Jilberto, Brennen McManus, Ahmad Moghrabi, et al.Circulation. Genomic and Precision Medicine|December 7, 2020
Associations Between Female Sex, Sarcomere Variants, and Clinical Outcomes in Hypertrophic CardiomyopathyNeal K Lakdawala, Iacopo Olivotto, Sharlene M Day, et al.Circulation. Genomic and Precision Medicine|August 26, 2020
Spatial and Functional Distribution of MYBPC3 Pathogenic Variants and Clinical Outcomes in Patients With Hypertrophic CardiomyopathyAdam S Helms, Andrea D Thompson, Amelia A Glazier, et al.Circulation|March 9, 2026
Differences in Disease Trajectory, Comorbidities, and Mortality in Sarcomeric and Nonsarcomeric Hypertrophic CardiomyopathyChristoffer R Vissing, Anna Axelsson Raja, Adam S Helms, et al.Pageof 16